New Delhi: The Centre is set to amend the New Drugs and Clinical Trials Rules, 2019, that would halve the statutory time to process applications for test licences to manufacture or use a new drug in clinical trials, promoting ease of doing business in the pharmaceutical sector. The Union health ministry sought public comments on…
Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority Nod We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Health Ministry Drafts Rule Change to Halve Drug Trial Approval Time from 90 to 45 Days We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
